Internship Cellular Biophysics, Lead Discovery (start date: no earlier than 1 September 2025, 6-12 months in Basel)
At Roche you can show up as yourself, embraced for the unique qualities you bring. Our culture encourages personal expression, open dialogue, and genuine connections, where you are valued, accepted and respected for who you are, allowing you to thrive both personally and professionally. This is how we aim to prevent, stop and cure diseases and ensure everyone has access to healthcare today and for generations to come. Join Roche, where every voice matters.
The PositionThe Lead Discovery (LD) department in Pharma Research and Early Development initiates and supports Small Molecule research projects by identifying screening hits and by providing key data and insights for their optimization in Medicinal Chemistry. Our department also contributes to the discovery of therapeutic proteins and supports emerging therapeutic modalities. We are a tightly knit community of many and diverse employees, closely collaborating with our therapeutic areas and other functions.
Your Opportunity:You are part of the biophysics team of LD with a natural interest in the interface to cellular assays.
You will explore the application of thermal denaturation methods in cellular context.
You are confident in hands on execution of in vitro methods, ideally fluorescence technologies and thermal denaturation methods (e.g. TSA, DSF).
You have a Master or Bachelor in biochemistry, biology, biophysics or a related life sciences field with background or interest in thermal denaturation methods and fluorescence spectroscopy
You are a dedicated and enthusiastic student with a talent and interest in applying biophysical methods and willingness to prepare samples in a cell-culture lab.
You are a proactive researcher with confidence and interest in establishing new ideas and knowledge in protein chemistry and cell culture is a plus.
A Current CV and a Motivation Letter
A certificate of enrolment (if you are currently studying).
For Non-EU/EFTA citizens: Due to regulations, you must provide a certificate issued by your university stating that an Internship is mandatory for your studies
Location: Basel, Switzerland
Target Start Date: 1 September 2025, or later, upon availability
Working hours: Full-time (40 hours per week)
Duration: 6-12 months
At Roche, you will have the opportunity to join an established early careers community, with a dedicated Early Careers Forum to share experiences, network and develop a broader understanding of the diverse functions in this pioneering healthcare company. This is a great opportunity to further develop your skills and create meaningful connections with other talents that are launching their careers.
Who we areA healthier future drives us to innovate. Together, more than 100’000 employees across the globe are dedicated to advance science, ensuring everyone has access to healthcare today and for generations to come. Our efforts result in more than 26 million people treated with our medicines and over 30 billion tests conducted using our Diagnostics products. We empower each other to explore new possibilities, foster creativity, and keep our ambitions high, so we can deliver life-changing healthcare solutions that make a global impact.
Let’s build a healthier future, together.
Roche is an Equal Opportunity Employer.
Similar Jobs
What We Do
Roche is a global pioneer in pharmaceuticals and diagnostics focused on advancing science to improve people’s lives. The combined strengths of pharmaceuticals and diagnostics under one roof have made Roche the leader in personalised healthcare – a strategy that aims to fit the right treatment to each patient in the best way possible.
Roche is the world’s largest biotech company, with truly differentiated medicines in oncology, immunology, infectious diseases, ophthalmology and diseases of the central nervous system. Roche is also the world leader in in vitro diagnostics and tissue-based cancer diagnostics, and a frontrunner in diabetes management.
Founded in 1896, Roche continues to search for better ways to prevent, diagnose and treat diseases and make a sustainable contribution to society. The company also aims to improve patient access to medical innovations by working with all relevant stakeholders. Thirty medicines developed by Roche are included in the World Health Organization Model Lists of Essential Medicines, among them life-saving antibiotics, antimalarials and cancer medicines. Roche has been recognised as the Group Leader in sustainability within the Pharmaceuticals, Biotechnology & Life Sciences Industry ten years in a row by the Dow Jones Sustainability Indices (DJSI).